US FDA’s NDIN Master File Draft Guidance Notes ‘No Presumption’ To Keep Information Confidential

FDA ODSP explains that whether information will be deemed a trade secret or otherwise confidential commercial information inaccessible to other firms in an NDIN master file is subject to Freedom of Information Act regulations and the relevant Food, Drug and Cosmetic Act rule.